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Purpose: Transrectal ultrasound-guided prostate biopsy is the procedure of choice for 
diagnosing prostate cancer. We compared with pain-relieving effect of acetaminophen, 
a known drug for enhancing the pain-relieving effect of tramadol, and eutectic mixture 
of local anesthetics (EMLA), a local anesthetic agent, with that of the conventional peri-
prostatic nerve block method.
Materials and Methods: This was a prospective, randomized, single-blinded study. A 
total of 430 patients were randomly assigned to three groups. Group 1 received a peri-
prostatic nerve block with 1% lidocaine, group 2 received acetaminophen 650 mg, and 
group 3 received EMLA cream for pain control. All patients were given 50 mg of tramadol 
intravenously 30 minutes before the procedure. At 3 hours after completion of the proce-
dure, the patients were asked to grade their pain on a horizontal visual analogue scale 
(VAS). The patients were also asked whether they were willing to undergo future biopsy 
if required.
Results: There were no significant differences between the three groups in terms of age, 
prostate-specific antigen, prostate size, or numbers of biopsy cores. The pain scores for 
groups 2 and group 3, which were 3.47±1.92 and 3.50±1.36, respectively, were similar 
and were significantly lower than that of group 1, which was 5.24±2.07.
Conclusions: Acetaminophen and EMLA cream with intravenous injection of tramadol 
are safe, easy, and effective methods of controlling pain during the procedure. These 
methods were more effective for pain relief than was the conventional periprostatic 
nerve block method.
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INTRODUCTION
As Korea also experiences the graying of society, aware-
ness of prostate cancer has increased, and with the in-
troduction of prostate-specific antigen (PSA), prostate can-
cer can be detected and treated early. The sensitivity of PSA 
to detect prostate cancer has been reported to be high. 
Recently, as its measurement has become standardized, 
the number of patients undergoing prostate biopsy is rising 
rapidly.
　In the past, finger-guided prostate biopsy was perfor-
med. Recently, however, owing to the development of pros-
tate ultrasonography, transrectal ultrasound-guided pro-
state biopsy has become the standard procedure. Transrec-
tal ultrasound-guided prostate biopsy is essential for the 
definite diagnosis of prostate cancer; nonetheless, it in-
duces pain in many cases. It has been reported that the pain 
is severe in approximately 19% to 25% of patients under-
going prostate biopsy [1-3]. In addition, many patients 
present with not only pain felt during the prostate biopsy Korean J Urol 2011;52:452-456
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TABLE 1. Characteristics of the patients undergoing biopsy
Total Group 1 Group 2 Group 3 p-value
No. patients
Age (yr)
PSA (ng/ml)
Prostate volume (ml)
Biopsy core number
430
66.2±9.7
10.4±13.8
42.9±21.0
10.4±0.8
125
65.9±8.5
10.1±11.5
44.0±19.2
10.5±0.8
158
67.4±10.3
11.0±12.4
42.8±26.3
10.0±0.1
147
65.3±10.0
10.1±16.7
42.1±15.4
10.4±0.8
0.161
0.81
0.759
0.456
PSA: prostate-specific antigen, Group 1: periprostatic nerve block using 1% lidocaine injection, Group 2: oral acetaminophen 650  mg, 
Group 3: eutectic mixture of local anesthetics cream (2.5% lidocaine, 2.5% prilocaine)
FIG. 1. Pain scale (0-10 visual analogue pain scale).
but also pain felt during the insertion of the transrectal ul-
trasound probe. Furthermore, it has been reported that ap-
proximately 20% of the patients do not wish to undergo 
prostate biopsy again unless the pain is reduced [1]. 
Therefore, numerous methods have been suggested to re-
duce the pain during transrectal ultrasound-guided pros-
tate biopsy [4-17]. Presently, to reduce the pain before pros-
tate biopsy, the most widely applied method is the peripro-
static nerve block method with 1% lidocaine [18]. Nonethe-
less, it does not sufficiently reduce pain in some cases.
　Tramadol is used for the reduction of pain in many fields, 
and acetaminophen has been reported to augment the an-
algesic effects of tramadol [19]. Eutectic mixture of local an-
esthetics (EMLA) cream (2.5% lidocaine, 2.5% prilocaine) 
is a topical anesthetic agent that is frequently used in the 
dermatologic and obstetric fields. In this study, we com-
pared with pain-relieving effect of acetaminophen and 
EMLA in addition to intravenous injection of tramadol 
with that of the conventional periprostatic nerve block 
method.
MATERIALS AND METHODS
This was a prospective, single-blinded randomized study 
performed in a tertiary urology center. The study subjects 
were selected from patients who visited the department of 
urology at our hospital during approximately 14 months 
from May 2009 to June 2010. The subjects were 430 pa-
tients who underwent transrectal ultrasound-guided pros-
tate biopsy, and all biopsies were performed by a single 
urologist. At the time of selection of the subjects, patients 
with prostatitis, chronic pelvic pain, or anal diseases such 
as hemorrhoids, anal fissure, and anal fistula were 
excluded. 
　By random assignment, the subjects were divided into 
the periprostatic nerve block group, in whom 1% lidocaine 
was injected (group 1); the oral acetaminophen 650 mg 
group (group 2); and the EMLA cream group (group 3). 
Thirty minutes before prostate biopsy, 50 mg tramadol was 
injected intravenously in all groups of patients, and 5 g of 
EMLA cream was applied 30 minutes before prostate biop-
sy to the peri-anal area and rectum in group 3. EMLA cream 
is known to allow dermal anesthesia and is specially ap-
plied to prevent pain associated with superficial surgical 
procedures. EMLA can be used under occlusive dressing. 
In our case, however, because the affected areas were the 
peri-anal area and rectum, occlusive dressing could not be 
applied. Regarding the number of prostate biopsy samples, 
10 cores or 12 cores were obtained randomly. The trans-
rectal ultrasound examinations were performed by using 
the General Electric LOGIQ400MD ultrasound machine 
and a 6 MHz transducer.
　Three hours after prostate biopsy, by a single-blind 
method, a third person evaluated the pain that was felt dur-
ing the insertion of the transrectal ultrasound probe by us-
ing a visual analogue scale (VAS) (Fig. 1). A score of 0 was 
defined as no pain, and 10 points was defined as the most 
severe intolerable pain. In addition, we surveyed whether 
the patients were willing to undergo another prostate biop-
sy in the future if required. After 3 days, the pain that devel-
oped during the biopsy and the presence of complications 
were assessed again in telephone interviews.
　For the statistical program, SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA) was used. Statistical analysis was per-
formed with ANOVA and Pearson chi-square test, and p- 
values less than 0.05 were considered to be statistically 
significant. 
RESULTS
The mean age of the 430 patients was 66.2±9.7 years, the 
average PSA was 10.4±13.8 ng/ml, the average prostate 
size was 42.9±21.0 ml, and the average number of biopsy 
cores was 10.4±0.8. The characteristics of the patients are 
shown in Table 1. There were no significant differences be-
tween the three groups.
　The average pain score at the time of insertion of the ul-
trasound probe and the pain score at the time of biopsy were Korean J Urol 2011;52:452-456
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TABLE 2. Pain score as assessed by use of a visual analogue scale
Total Group 1 Group 2 Group 3 p-value
Probe insertion pain score
Biopsy pain score
Willing to biopsy next (%)
4.12±2.20
3.90±1.78
281/430 (65.3)
5.24±2.07
4.90±1.66
69/125 (55.2)
3.77±2.25
3.47±1.92
107/158 (67.7)
3.56±1.92
3.50±1.36
105/147 (71.4)
＜0.05
＜0.05
＜0.05
Group 1: periprostatic nerve block using 1% lidocaine injection, Group 2: oral acetaminophen 650 mg, Group 3: eutectic mixture of 
local anesthetics cream (2.5% lidocaine, 2.5% prilocaine)
TABLE 3. Complications after biopsy
Total Group 1 Group 2 Group 3
Acute prostatitis 
Vasovagal syncope 
Anal bleeding 
1
1
5
0
0
1
0
1
2
1
0
2
Group 1: periprostatic nerve block using 1% lidocaine injection,
Group 2: oral acetaminophen 650 mg, Group 3: eutectic mixture 
of local anesthetics cream (2.5% lidocaine, 2.5% prilocaine)
4.12±2.20 and 3.90±1.78, respectively, and the percentage 
of patients who indicated that they would be willing to un-
dergo rebiopsy if needed was 65.3% (281 of 430 patients). 
The pain scores and willingness to undergo rebiopsy are 
shown in Table 2. The pain scores at the time of insertion 
of the ultrasound probe and at the time of biopsy were sim-
ilar for group 2 and group 3. However, they were sig-
nificantly lower than the pain scores of group 1 (p＜0.05) 
(Table 2). Similarly, the percentages of patients willing to 
undergo rebiopsy in group 2 and group 3 were 67.6% 
(107/158) and 71.4% (105/147), respectively, which was sig-
nificantly higher than in group 1 (55.2%; 69/125) (p＜0.05).
　Regarding side effects that developed after prostate biop-
sy, there was 1 case of acute prostatitis, 1 of vasovagal, and 
5 of rectal bleeding (Table 3). The patient who developed 
acute prostatitis in group 3 was discharged after intra-
venous injection of antibiotics for 2 days. The patient who 
developed vasovagal syncope in group 2 was stabilized by 
bed rest and hydration without any other special treat-
ment. Regarding the 5 cases of rectal bleeding, 1 patient 
was from group 1, 2 patients were from group 2, and 2 pa-
tients were from group 3. The bleeding in all cases was stop-
ped within 30 minutes and no additional hospitalization or 
outpatient visits were required. Similarly, in the telephone 
interview conducted 3 days after biopsy, it was found that 
no additional pain or other complications had developed.
DISCUSSION
With the prolongation of the average life span, the in-
cidence of prostate cancer has rapidly increased worldwide 
in recent years. In 2005, in America, the number of patients 
who experienced prostate biopsy increased such that more 
than 770,000 cases of transrectal ultrasound-guided pros-
tate biopsy were performed. Recent statistics indicate that, 
even if cancer is not detected at the initial biopsy, it is de-
tected at rebiopsy in 21% to 29% cases [20-22], and thus the 
importance of rebiopsy has been emphasized. The greatest 
factor contributing to patients’ refusal to undergo rebiopsy 
may be the pain felt at the time of the initial biopsy. 
Redelmeier et al reported that when colonoscopy is per-
formed repeatedly on patients who have experienced colo-
noscopy once, their pain score is higher than that of pa-
tients undergoing colonoscopy for the first time [23]. 
Therefore, from the aspect of reducing the discomfort of pa-
tients, pain reduction is important and it is thought to play 
a role in the willingness to undergo rebiopsy if needed. In 
our study, not only the pain at the time of the prostate biop-
sy but also the willingness regarding rebiopsy were 
studied. In addition, similar to colonoscopy, pain scores 
may be increased due to previous experiences; thus, in our 
study, patients who experienced prostate biopsy in the past 
were excluded.
　Transrectal ultrasonography was first applied to exam-
ine the prostate in 1963 by Takahashi and Ouchi [24]. In 
1989, Hodge et al performed transrectal ultrasound-guid-
ed 6-core prostate biopsy [25]. Afterward, this method was 
used as the standard method for the diagnosis of prostate 
cancer. To raise the rate of diagnosis, the method has been 
modified to include an increased number of biopsy cores. 
Recently, efforts have been made to reduce the pain of pa-
tients, and bleeding, infection, and other complications 
caused by biopsy have been considered. 
　Although numerous studies on the methods used to re-
duce pain have been conducted in Korea as well as in other 
countries, to date, standard procedures have not been 
established. Currently, the most widely used method for 
pain reduction is the nerve block method using 1% lido-
caine before biopsy [18]. Additional methods are the appli-
cation of lidocaine gel to the rectum and the periprostate 
area [5-10], injection of diclofenac or ketorolac [11,12], mid-
azolam administration [13], inhalation anesthesia using 
N2O [14,15], and intravenous anesthesia using propofol 
[16,17]. From the aspect of convenience and effectiveness, 
however, whether to consider these as standard proce-
dures is controversial.
　Irani et al have reported that the application of lidocaine 
gel to the rectum and the peri-prostate area was effective; 
however, a control group was not included in that  study 
[1]. Desgrandchamps et al compared a group in which 2% 
lidocaine was applied to the rectum with a control group Korean J Urol 2011;52:452-456
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TABLE 4. Patients with visual analogue scale score≥7 
Total Group 1 Group 2 Group 3 p-value
Probe insertion pain score (%)
Biopsy pain score (%)
  73/430 (17.0)
32/430 (7.4)
45/125 (36)
   24/125 (19.2)
19/158 (12.0)
6/158 (3.8)
9/147 (6.1)
2/147 (1.7)
＜0.05
＜0.05
Group 1: Periprostatic nerve block using 1% lidocaine injection, Group 2: Oral acetaminophen 650 mg, Group 3: eutectic mixture of
local anesthetics cream (2.5% lidocaine, 2.5% prilocaine)
in which ultrasound gel was applied and reported that the 
application of lidocaine to the rectum did not improve the 
patients’ pain at the time of biopsy [26]. In Korea, Song et 
al showed that the pain level of a group in whom lidocaine 
was applied to the rectum was not significantly different 
from that of a control group in whom saline was injected 
into the periprostatic area [27]. Although numerous stud-
ies have been performed on the application of lidocaine gel 
to the rectum and the periprostatic area, concurrent effects 
have not been reported [5-8,10]. The anesthetic effect of the 
injection of diclofenac or ketorolac alone is relatively in-
sufficient, and thus cases without sufficient reduction of 
pain are frequently seen. Sedatives such as midazolam 
may induce severe side effects such as delirium, confusion, 
amnesia, and respiratory failure, and elderly males are 
more vulnerable to the development of these complications 
[28]. Because many people have an aversion to general an-
esthesia, inhalation anesthesia with N2O and intravenous 
anesthesia with propofol are difficult to perform in reality, 
and these methods are also cost-ineffective.
　The purpose of this study was to assess the effect of the 
oral administration of 650 mg acetaminophen and EMLA 
cream in addition to intravenous injection of tramadol and 
to compare their effects with the conventional method used 
to reduce pain. The VAS, a method that is used in many 
fields to assess pain, was used for the comparison. The VAS 
can be used regardless of age, language, and race, and be-
cause it is numerically assessed, it is a good method for com-
paring pain statistically.
　The results of our study showed that in comparison with 
the conventional periprostatic nerve block method, the 
pain-relieving effect of the oral administration of 650 mg 
acetaminophen and the application of EMLA cream was 
excellent, and no side effects induced by the drugs were 
detected. In particular, the advantage of the oral admin-
istration of 650 mg acetaminophen and the topical applica-
tion of EMLA cream is that the pain caused by use of the 
needle for injection of the 1% lidocaine does not occur. When 
the periprostatic nerve block procedure is performed, the 
number of needle injections is increased in addition to con-
ventional biopsy by more than two, which may be asso-
ciated with complications such as prostatitis and bleeding. 
However, in our study, the complication rate of group 1, in 
which nerve block was performed, was not significantly dif-
ferent from that of groups 2 and 3, in which nerve block was 
not performed. These findings agree with the study re-
ported by Obek et al [29].
　In the evaluation of VAS pain scores, scores of 1 to 3 are 
considered mild, 4 to 6 moderate, and ≥7 severe [30]. In 
this study, the average pain scores of the three groups 
showed mild to moderate pain scores. The ratios of the pa-
tients presenting with severe pain (≥7) at the time of probe 
insertion were 36% (group1), 12.0% (group 2), and 6.1% 
(group 3). The ratios at the time of biopsy were 19.2% (group 
1), 3.8% (group 2), and 1.7% (group 3). The differences be-
tween the three groups were all significant (Table 4).
　The anxiety and pain caused by prostate biopsy are asso-
ciated with the anal pain induced by the ultrasonography 
probe insertion and the pain induced by the needles at the 
time of biopsy. However, the anal pain during probe in-
sertion is known to cause more pain than the biopsy itself 
[26]. In our study, similarly, comparable results were ob-
served, and in comparison with group 1, the anal pain that 
developed at the time of the insertion of the ultra-
sonography probe in groups 2 and 3 was statistically sig-
nificantly reduced.
　The advantages of our study were that the biopsies were 
performed by a single urologist, and thus our study is supe-
rior to other studies in which biopsies were performed by 
several urologists. In addition, the oral administration of 
acetaminophen before prostate biopsy or the use of EMLA 
cream are simple, side effects were rare, the pain that de-
veloped at the time the ultrasonography probes passed 
through the anus and the pain that developed at the time 
of biopsy could be reduced, and willingness to undergo re-
biopsy was increased. Regarding selecting a preferable 
method, patients' kidney and liver functions as well as their 
perirectal skin condition should be taken under consid-
eration, because acetaminophen can cause hepatitis or re-
nal insufficiency, although very rarely, and EMLA should 
not be used with open wounds.
　A potential imitation of our study is that the VAS is a very 
subjective index. The absence of a control group with tra-
madol is also a limitation, because tramadol may have ach-
ieved significant relief of pain.
CONCLUSIONS
According to the results of our study, oral administration 
of 650 mg acetaminophen and topical application of EMLA 
cream, in addition of intravenous tramadol, reduce pain 
and are both technically easy, noninvasive, and safe. 
Moreover, these methods were more effective for pain relief 
than was the conventional periprostatic nerve block 
method. Therefore, they are thought to be useful methods 
of relieving pain during prostate biopsy.Korean J Urol 2011;52:452-456
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